Penn Medicine Abramson Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Penn Medicine Abramson Cancer Center

Minimizing the Impact of a Prostate Cancer Diagnosis
11th Neuro-Oncology Brain Tumor Symposium
2024 Updates in Care of the Hematologic Malignancies Patient
11th Focus on Leukemia, Lymphoma, Myeloma & Cellular Therapies
18th Wallace H. Clark Jr, MD Lectureship in Cutaneous Oncology and Melanoma Symposium
2023 Breast Cancer Highlights from International Medical Meetings: Fourth Annual Review
Cellicon Valley '23: The Future of Cell and Gene Therapies
Plenary Sessions Concurrent Sessions
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium
Keynote and Plenary Sessions Concurrent Sessions
2021 Updates in Care of the Hematologic Malignancies Patient
New Therapies and Current Patient Management of Lymphomas Update on Patient Care Treatment Strategies in Leukemia Controversies and Update for Patient Care in Multiple Myeloma COVID-19
2020 Updates in Care of the Hematologic Malignancies Patient
New Therapies and Current Patient Management of Lymphomas Update on Patient Care Treatment Strategies in Leukemia Update in Blood and Marrow Transplantation and Cellular Therapy Controversies and Update for Patient Care in Multiple Myeloma
2023
Updates in Oncology 2023 Philadelphia 2023 Updates in Care of The Hematologic Malignancies Patient
2022
Precision Surgery Intraoperative Molecular Imaging 2022 Sarcoma Management: Case-Based Discussion Primary Hyperparathyroidism: A Multidisciplinary Case Review Updates in Oncology 2022 Philadelphia 17th Wallace H. Clark Jr, MD Lectureship in Cutaneous Oncology and Melanoma Symposium Annual Updates in Management of Thyroid Nodules Management and Updates of Medullary Thyroid Cancer 2022 Breast Cancer Highlights From International Medical Meetings: Third Annual Review A Multidisciplinary Approach to the Management of Melanoma & Cutaneous Carcinoma 2022 Updates in Care of the Hematologic Malignancies Patient Updates on Colorectal Liver Metastases: A Multidisciplinary Approach
2021
4th Pituitary Update Updates in Oncology 2021 Philadelphia: With Proceedings From International Medical Meetings 2021 Breast Cancer Highlights From International Medical Meetings: Second Annual Review
2020
COVID-19 2020 Updates in Oncology
2019
Immunotherapy CNS
Webinars
Updates on Breast Care and Imaging During COVID: Vaccines, Screenings and Treatment Updates in Pancreatic Cancer: A Team Approach to Complex Care Updates in Management of Sarcoma: Local Treatment, Clinical Trials, and the Future of Sarcoma Care Updates in Melanoma: Treatment, Clinical Trials and Coexisting with COVID-19 Updates in Thoracic Oncology: Treatment, Clinical Trials and Coexisting with COVID-19
Videos
Events

Playback speed

10 seconds

Low-Risk Thyroid Cancer Surgery Approach: What Are the Factors Influencing the Extent of Surgery? Unilateral vs. Bilateral Thyroidectomy

By Penn Medicine Abramson Cancer Center FEATURING Heather Wachtel

55 views

March 4, 2021

Comments 0

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Videos

WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Ther…

Insights from 2024 WCLC

M. Marmarelis

88 views

WCLC 2024 Insights: Long-Term Follow Up on Pembro + Itacitinib in PD…

Insights from 2024 WCLC

M. Marmarelis

21 views

A Multidisciplinary Team Approach to TTP

Penn Medicine Abramson Cancer Center

D. Siegel

170 views

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dorman…

Insights from 2023 ESMO Annual Meeting

A. DeMichele

90 views

SOHO 2023 Results from the QuANTUM-First Trial: Impact of allo-HCT i…

SOHO 2023 Eleventh Annual Meeting

A. Perl

49 views

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…

Total Health

A. Smith

167 views

2023 ASCO® Direct Philadelphia: Phase 3 SHAPE Trial - Radical vs. Si…

Total Health

A. Smith

101 views

2023 ASCO® Direct Philadelphia: RUBY Trial Review - Dostarlimab + Ch…

Total Health

A. Smith

80 views

Metastatic NSCLC Updates - 2023 ASCO® Direct Philadelphia

Total Health

S. Kazmi

140 views

2023 ASCO® Direct Philadelphia: TRANSCEND CLL 004 Study - CLL/SLL Up…

Total Health

J. Svoboda

17 views

2023 ASCO® Direct Philadelphia: Phase 3 ZUMA-7 Study - R/R DLBCL Upd…

Total Health

J. Svoboda

52 views

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

Total Health

J. Svoboda

171 views

Surgical Management of CRC Liver Metastases - 2023 ASCO® Direct Phil…

Total Health

R. Roses

99 views

Perioperative Therapy for Early Stage NSCLC - Best of Lung 2023

Total Health

S. Kazmi

201 views

ADAURA Trial Update: Osimertinib in Resected EGFRm NSCLC - Best of L…

Total Health

S. Kazmi

121 views

Neoadjuvant Therapy for Resectable Melanoma

International Congress on Cancer Metastasis

G. Karakousis

182 views

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

302 views

Treatment Strategies in ALL: Journey to MRD Negativity

Penn Medicine Abramson Cancer Center

C. Lai

76 views

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …

ASCO GI 2023 Conference Coverage

K. Reiss Binder

132 views

The Role of Adjuvant Targeted Therapy in rNSCLC

Penn Medicine Abramson Cancer Center

M. Marmarelis

451 views

2022 Delivery of Care for Cancer Patients During the COVID-19 Pandem…

Penn Medicine Abramson Cancer Center

L. Schuchter

7 views

Update on Treatment of COVID-19 Infection for Cancer and Other Immun…

Penn Medicine Abramson Cancer Center

K. Murphy

10 views

Update on Treatment and Prevention of COVID-19 in Cancer Patients

Penn Medicine Abramson Cancer Center

A. Garfall

345 views

Penn Medicine Updates on the Advances in BRCA-Related Breast Cancer …

Penn Medicine Abramson Cancer Center

S. Domchek

108 views

Updates and Management of Medullary Thyroid Cancer: Genetic Testing …

Penn Medicine Abramson Cancer Center

V. Livolsi, K. Nathanson, L. L. Sun, R. Kelz, S. Mandel

307 views

Advances in Adjuvant Therapy in NSCLC

Penn Medicine Abramson Cancer Center

C. Ciunci

884 views

47 y/o Male With Papillary Thyroid Cancer: How to Plan Surgery Strat…

Penn Medicine Abramson Cancer Center

S. Mandel, A. Chalian, S. Swisher-Mcclure

56 views

47 y/o Male With Papillary Thyroid Cancer: Radioiodine-131 Planning …

Penn Medicine Abramson Cancer Center

S. Mandel, D. Pryma

36 views

47 y/o Male With High-Risk Thyroid Cancer: How Does Surveillance Wor…

Penn Medicine Abramson Cancer Center

S. Mandel, M. Brose

30 views

47 y/o Male With High-Risk Thyroid Cancer: What Is the Right Timing …

Penn Medicine Abramson Cancer Center

S. Mandel, M. Brose, A. Chalian, D. Pryma, S. Swisher-Mcclure

30 views

Attributes of Low-Risk Thyroid Cancer: How to Predict Risk? AJCC TNM…

Penn Medicine Abramson Cancer Center

S. Mandel

20 views

Low-Risk Thyroid Cancer Surgery Approach: What Are the Factors Influ…

Penn Medicine Abramson Cancer Center

H. Wachtel

55 views

The Histopathology of Low-Risk Thyroid Cancer: How to Assess and Ide…

Penn Medicine Abramson Cancer Center

J. Jalaly

17 views

Radioiodine Therapy for Low-Risk Thyroid Cancer: When Should I-131 T…

Penn Medicine Abramson Cancer Center

B. Cooperberg

20 views

Management of Low-Risk Thyroid Cancer: Is There a Difference in Recu…

Penn Medicine Abramson Cancer Center

S. Mandel

34 views

53 y/o Female With Papillary Thyroid Cancer, Two Suspicious R Latera…

Penn Medicine Abramson Cancer Center

B. Cooperberg, S. Mandel, H. Wachtel

21 views

UPenn 2020 ASCO Updates on Early Local Therapy in mBC: Does ELT Impr…

Penn Medicine Abramson Cancer Center

A. Mateo

96 views

UPenn 2020 ASCO Updates on HER2+ Ductal Carcinoma in Site: Does Tras…

Penn Medicine Abramson Cancer Center

A. Mateo

76 views

UPenn 2020 ASCO Updates on mTNBC: Does the Addition of Pembro to Che…

Penn Medicine Abramson Cancer Center

J. Matro

88 views

UPenn 2020 ASCO Updates on PARPi in mTNBC: Does Veliparib Improve Ch…

Penn Medicine Abramson Cancer Center

J. Matro

24 views

UPenn 2020 ASCO Updates on Operable TNBC: What Is the Role of Adjuva…

Penn Medicine Abramson Cancer Center

J. Matro

112 views

UPenn 2020 ASCO Updates on ET in MBC: Is Fulvestrant + Alpelisib Eff…

Penn Medicine Abramson Cancer Center

P. Gor

131 views

UPenn 2020 ASCO Updates on Adjuvant ET in BC: In Pts Treated With an…

Penn Medicine Abramson Cancer Center

P. Gor

19 views

Updates on HER2+ MBC: HER2CLIMB OS/PFS Data on Tucatinib Combo in Pa…

Penn Medicine Abramson Cancer Center

H. Knollman

728 views

UPenn Updates on HER2+ EBC: CT De-Escalation Using F-PET, Adjuvant T…

Penn Medicine Abramson Cancer Center

T. D'Entremont

101 views

UPenn 2020 ASCO Updates on Stage 2/3 HER2+ BC: Do Anthracyclines Imp…

Penn Medicine Abramson Cancer Center

H. Knollman

168 views

UPenn 2020 ASCO Updates on Adjuvant ET in BC: Does the 70-Gene Signa…

Penn Medicine Abramson Cancer Center

P. Gor

14 views

UPenn 2020 ASCO Breast Cancer Q&A: Preoperative Anthracyclines for H…

Penn Medicine

H. Knollman, A. Mateo, J. Matro, T. D'Entremont

285 views

TumorGlow®: Illuminating Cancer Cells in the Operating Room

Penn Medicine Abramson Cancer Center

167 views

Advances in Precision Surgery with Penn Medicine’s TumorGlow™ Techno…

Penn Medicine Abramson Cancer Center

S. Singhal